These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14606663)

  • 1. An attempt to stabilize nilvadipine solid dispersion by the use of ternary systems.
    Hirasawa N; Ishise S; Miyata H; Danjo K
    Drug Dev Ind Pharm; 2003 Oct; 29(9):997-1004. PubMed ID: 14606663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of nilvadipine solid dispersion to tablet formulation and manufacturing using crospovidone and methylcellulose as dispersion carriers.
    Hirasawa N; Ishise S; Miyata H; Danjo K
    Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):244-7. PubMed ID: 14758011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterization and drug release studies of nilvadipine solid dispersions using water-insoluble polymer as a carrier.
    Hirasawa N; Ishise S; Miyata H; Danjo K
    Drug Dev Ind Pharm; 2003 Mar; 29(3):339-44. PubMed ID: 12741614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stability of nilvadipine solid dispersion tablet with non-packaging condition].
    Hirasawa N; Ishise S; Miyata H
    Yakugaku Zasshi; 2004 Jan; 124(1):19-23. PubMed ID: 14768351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, Characterization and Stability Studies of Glassy Solid Dispersions of Indomethacin using PVP and Isomalt as carriers.
    Khodaverdi E; Khalili N; Zangiabadi F; Homayouni A
    Iran J Basic Med Sci; 2012 May; 15(3):820-32. PubMed ID: 23493157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
    Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
    Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of spray drying process parameters on the solubility behavior and physical stability of solid dispersions prepared using a laboratory-scale spray dryer.
    Kojima Y; Ohta T; Shiraki K; Takano R; Maeda H; Ogawa Y
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1484-93. PubMed ID: 22670826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30.
    Damian F; Blaton N; Kinget R; Van den Mooter G
    Int J Pharm; 2002 Sep; 244(1-2):87-98. PubMed ID: 12204568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.
    Ghanavati R; Taheri A; Homayouni A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():501-511. PubMed ID: 28024614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.
    Friedrich H; Nada A; Bodmeier R
    Drug Dev Ind Pharm; 2005 Sep; 31(8):719-28. PubMed ID: 16221606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of domperidone solid dispersions.
    Essa EA; Balata GF
    Pak J Pharm Sci; 2012 Oct; 25(4):783-91. PubMed ID: 23009995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of a solid dispersion of felodipine using a solvent wetting method.
    Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
    Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.